Hugh Martin served as the CEO of Pacific Biosciences of California, Inc. for a brief period in early 2012. His leadership came at a time when the company was focused on advancing DNA sequencing technologies, essential for many modern scientific...

Hugh Martin served as the CEO of Pacific Biosciences of California, Inc. for a brief period in early 2012. His leadership came at a time when the company was focused on advancing DNA sequencing technologies, essential for many modern scientific breakthroughs. Before stepping down, he received a compensation package that totaled around $304,615, which included a salary but did not feature cash bonuses or stock grants for that year. Interestingly, during his tenure, he held significant stock options, allowing him to benefit financially from the company's performance. Martin's decision to leave was sudden, influenced by personal reasons, and he resigned from his roles as CEO and Chairman just days into the new year, but continued as a board director briefly afterwards. He has been involved in stock trades, showing fluctuations in his holdings which peaked in 2021, indicating times when he saw significant value in his shares.